Alert
CLOSE
Alert
Community Information

Sustained transmission with high likelihood or confirmed exposure within communal settings and potential for rapid increase in cases.

Emergency Notifications

Cardinal Flight Plan

Resources for learning online here

UIW COVID-19 Community Updates and Operations Information

Illness Reporting Form

UIW Employee COVID-19 Vaccine Policy

All employees are required to be fully vaccinated for the COVID-19 virus with a deadline to report your vaccination status by October 31, 2021. If you have not already done so, please upload your status to Med-Proctor, which can be accessed through Cardinal Apps.

We hope that by requiring the vaccine for our employee community, we can provide the safest possible environment and educational experience for our staff, students, and area community. We look to the words of Archbishop Gustavo Garcia-Siller, who stated that being vaccinated is “…an act of love of our neighbor and part of our moral responsibility for the common good.”

The policy applies to employees of all classifications working in any location, including on-campus or remotely. Below you will find the vaccine policy, vaccine FAQs and helpful instructions on how to report your vaccination status.

COVID-19 Vaccine

What is COVID-19?

COVID-19 is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea. Severe cases of COVID-19 may result in hospitalization or even death.

Who should get the vaccine

On December 11, 2020, the FDA issued an  Emergency Use Authorization (EUA) for the use of the Pfizer-BioNTech COVID-19 vaccine in persons aged 16 years and older and on December 13, 2020, ACIP issued recommendation for the use of Pfizer-BioNTech’s COVID-19 vaccine for the prevention of COVID-19. Children 12 years and older are now able to get the  Pfizer-BioNTech COVID-19 Vaccine .

On December 18, 2020, the U.S.. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older.

On February 27, 2021, the U.S.. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19). The EUA allows the Janssen (Johnson & Johnson) COVID-19 Vaccine to be distributed in the U.S.. for use in individuals 18 years of age and older.

Who should not get this vaccine

  • If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction — even if it was not severe — to any ingredient in an mRNA COVID-19 vaccine, you should not get an mRNA COVID-19 vaccine.
  • If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction—even if it was not severe—after getting the first dose of the vaccine, you should not get another dose of an mRNA COVID-19 vaccine.
  • An immediate allergic reaction means a reaction within 4 hours of getting vaccinated, including symptoms such as hives, swelling, or wheezing (respiratory distress).
  • This includes allergic reactions to polyethylene glycol (PEG) and polysorbate. Polysorbate is not an ingredient in either mRNA COVID-19 vaccine but is closely related to PEG, which is in the vaccines. People who are allergic to PEG or polysorbate should not get an mRNA COVID-19 vaccine.

Most common side effects

In the arm where you got the shot:

  • Pain
  • Swelling
  • Redness

Throughout the rest of your body:

  • Chills
  • Tiredness
  • Headache

Safety Data

  • The above side effects are common but are mostly mild to moderate in clinical trials.
  • Side effects (such as fever, chills, tiredness, and headache) were more common after the second dose of the vaccine.

Most side effects were mild to moderate. However, a small number of people had severe side effects, defined as side effects affecting a person’s ability to do daily activities.

To learn more about COVID-19 vaccines and allergic reactions please review here

How well does the vaccine work

  • The Pfizer-BioNTech vaccine was 95% effective at preventing laboratory-confirmed COVID-19 illness in people without evidence of previous infection.
  • The Moderna vaccine was 94.1% effective in preventing COVID-19 disease among clinical trial participants.
  • Among clinical trial participants, the Janssen vaccine was approximately 67% effective in preventing moderate to severe/critical COVID-19 disease occurring at least 14 days after vaccination and 66% effective in preventing moderate to severe/critical disease at least 28 days after vaccination. Additionally, the vaccine was approximately 77% effective in preventing severe/critical COVID-19 occurring at least 14 days after vaccination and 85% effective in preventing severe/critical COVID-19 occurring at least 28 days after vaccination.
  • The COVID-19 vaccines have demonstrated efficacy at preventing severe and symptomatic COVID-19.
  • Vaccinated persons with an exposure to someone suspected or confirmed COVID-19 will not be required to quarantine if they meet all of the following criteria:
    • Are fully vaccinated (i.e., > or equal 2 weeks following receipt of the second dose in a 2-dose series, or ≥2 weeks following receipt of one dose of a single-dose vaccine)
    • Are within 3 months following receipt of the last dose in the series
    • Have remained asymptomatic since the current COVID-19 exposure

Learn More About Each of the COVID-19 Vaccines

Click the links below for more information about the Pfizer-BioNTech, Moderna and Janssen COVID-19 vaccines from the U.S. Food and Drug Administration.

 Back to Top